Cargando…
Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study”
Autores principales: | Karina, Karina, Martin Christoffel, Louis, Novariani, Rita, Rosadi, Imam, Rosliana, Iis, Rosidah, Siti, Sobariah, Siti, Fatkhurohman, Novy, Puspitaningrum, Nurlaela, Hertati, Yuli, Afini, Irsyah, Ernanda, Difky, Widyastuti, Tias, Sulaeha, A. D., Zakiyah, Alfida, Aini, Noor, Krisandi, Grady, Andrew, Hubert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918366/ https://www.ncbi.nlm.nih.gov/pubmed/36776281 http://dx.doi.org/10.1155/2023/9846961 |
Ejemplares similares
-
The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study
por: Karina, Karina, et al.
Publicado: (2021) -
Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients
por: Karina, Karina, et al.
Publicado: (2021) -
In vitro study of cartilage tissue engineering using human adipose-derived stem cells induced by platelet-rich plasma and cultured on silk fibroin scaffold
por: Rosadi, Imam, et al.
Publicado: (2019) -
Breakthrough in treating severe coronavirus disease 2019 (COVID-19) patients in indonesia: the use of intravenous autologous activated platelet-rich plasma
por: Karina, K., et al.
Publicado: (2021) -
Safety of Technique and Procedure of Stromal Vascular Fraction Therapy: From Liposuction to Cell Administration
por: Karina, Karina, et al.
Publicado: (2020)